Meyler's Side Effects of Drugs is a well-produced book and is one of the best resources on adverse reactions and interactions of drugs. As indicated in the pref . Article in PDF ( KB) Meyler's side effects of drugs: The international encyclopedia of adverse drug reactions and interactions Separate indexes of the drug names, adverse effects and adverse reactions and drug-drug. 𝗣𝗗𝗙 | On Mar 1, , N. M. Cass and others published Book Review: Meyler's Side Effects of Drugs Used in Anesthesia.
|Language:||English, Spanish, Indonesian|
|ePub File Size:||29.54 MB|
|PDF File Size:||15.86 MB|
|Distribution:||Free* [*Sign up for free]|
Cover for Meyler's Side Effects of Drugs searchability, extensive internal cross- linking and fully downloadable and printable full-text, HTML or PDF articles. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug and fully downloadable and printable full-text, HTML or PDF articles. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, Sixteenth Edition builds on the success of the
It has grown to six volumes and is now arranged alphabetically into drug monographs, rather than by chapters on drug classes. More than 1, monographs cover areas ranging from drug classes e. Monographs address adverse effects on each organ system; long-term effects; second-generation effects; effects on specific populations based on age, disease state, etc. Extensive indexes list drug names and indicate which drugs cause particular reactions--especially helpful for clinicians. Meyler's comes out every four years and is updated yearly with the shorter Side Effects of Drugs Annual.
There are literally tens of thousands of publication references including on contraceptive hormones alone. Most date back many years. It provides primarily qualitative information on the millions of reported adverse effects obtained from spontaneous, anecdotal case reports on the thousands of marketed drugs reported to agencies and journals.
The value and substantial limitations of these reports are described in the Preface written by I. To this reviewer, this extensive volume may be of some value to health professionals as a reference, but will be less valuable to investigators since the discussion of formal epidemiologic studies is limited and generally uncritical.
Indeed, it is surprising and disappointing that the principles and methods of such studies which have been extensive and ongoing for more than 40 years are given scant attention. When they are discussed in individual chapters for drug groups such as nonsteroidal anti-inflammatory drugs and contraceptive and noncontraceptive hormones, the presentations are incomplete and uncritical in terms of the quality of the research. For example, the discussion of the important and somewhat controversial finding of an increased risk of idiopathic venous thromboembolism in users of third generation oral contraceptives containing gestodene and desogestrel compared with users of oral contraceptives containing levonorgestrel is summarized in one sentence.
Only one of the original three papers on the subject published in the Lancet in and none of the additional studies is referenced. All of the many properly conducted studies provide control for age, calendar time, smoking and body mass index.
The information of most direct value that this reference text provides relates to proposed drug interactions and pharmacodynamics. Most such studies are derived from well conducted experimental studies. Summaries Bowker Data Service Summary A completely new edition of what has become the standard reference text in the field of adverse drug reactions and interactions since Leopold Mayler published his first review of the subject 55 years ago.
Main Description Building on the success of the 14 previous editions, this remarkable reference has been extensively reorganized and expanded and now comprises almost 1, individual drug articles providing the most complete coverage of adverse reactions and interactions found anywhere. Each article contains detailed and authoritative information about the adverse effects of each drug, with comprehensive references to the primary literature making this a must have for any academic or medical library, pharmacologist, regulatory organization, hospital dispensary or pharmaceutical company.
Now available online for all academic, corporate or government institution as well as individuals via Science Direct! The online version provides an unparalleled depth of coverage and functionality by offering convenient desktop access and enhanced features such as increased searchability, extensive internal cross-linking and fully downloadable and printable full-text, HTML or PDF articles.
Opportunities are afforded by recent progress in genetic knowledge and manipulation that facilitate pharmaceutical management of disease processes to an unprecede Main Description The pharmaceutical industry is currently faced with formidable opportunities and challenges.
Opportunities are afforded by recent progress in genetic knowledge and manipulation that facilitate pharmaceutical management of disease processes to an unprecedented degree.
Challenges include the need to produce more clinically relevant drugs to market faster than competitors.
The risk in meeting this challenge is that of safety. Recent events, such as the withdrawal of COX-2 inhibitors from the market in the face of reported adverse effects, have proven very damaging to the companies involved, as well as to the government agencies charged with drug approval.
Thus, the availability of accurate, evaluated information on adverse effects is increasingly a critical market need. Building on the success of previous editions, this key title has been extensively reorganised and expanded and now comprises almost 1, individual drug articles. Each article contains detailed and authoritative information about the adverse effects of each drug, with comprehensive references to the primary literature.